Status:
RECRUITING
Evaluation of the JUICE HA® as an Anti-sarcopenia
Lead Sponsor:
China Medical University Hospital
Conditions:
Sarcopenia in Elderly
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo...
Detailed Description
JUICE HA® is a nutritional supplement formulated with hyaluronic acid (HA), branched-chain amino acids (BCAA), and chondroitin. Hyaluronic acid contributes to enhancing hydration levels in the skin an...
Eligibility Criteria
Inclusion
- Participants that have been diagnosed with sarcopenia by a physician and meet the AWGS 2019 criteria for sarcopenia.
Exclusion
- Participants with a history of severe lower extremity musculoskeletal injuries within the past six months or those who have a fear of blood sampling will be excluded.
Key Trial Info
Start Date :
June 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 13 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06950125
Start Date
June 13 2025
End Date
March 13 2026
Last Update
July 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, 404327